NMTC — Neuroone Medical Technologies Balance Sheet
0.000.00%
Last trade - 00:00
- $30.60m
- $27.92m
- $3.45m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.261 | 4.04 | 6.9 | 11.1 | 5.32 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.048 | 0.033 | 0 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.302 | 4.16 | 7.29 | 12.2 | 7.31 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.052 | 0.448 | 0.512 | 0.535 | 0.695 |
Net Intangible Assets | |||||
Total Assets | 0.533 | 4.76 | 7.94 | 12.8 | 8.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.77 | 2.36 | 1.18 | 3.1 | 1.79 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.77 | 2.69 | 1.38 | 3.22 | 1.85 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -1.24 | 2.07 | 6.55 | 9.6 | 6.25 |
Total Liabilities & Shareholders' Equity | 0.533 | 4.76 | 7.94 | 12.8 | 8.1 |
Total Common Shares Outstanding |